{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:44:06Z","timestamp":1786981446553,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11060-017-2606-6","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T01:01:04Z","timestamp":1504054864000},"page":"465-472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p\/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil"],"prefix":"10.1007","volume":"135","author":[{"given":"Dayane B.","family":"Koshiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Graziadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael F. M.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana","family":"Cunegatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliete","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina O.","family":"Provenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre P.","family":"de S\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano P.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00edra C.","family":"Velho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"de A. P. Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceres A.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-4877","authenticated-orcid":false,"given":"Paulo R. G.","family":"Zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"issue":"5","key":"2606_CR1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492\u2013507","journal-title":"N Engl J Med"},{"issue":"3","key":"2606_CR2","first-page":"212","volume":"54","author":"E Necesalov\u00e1","year":"2007","unstructured":"Necesalov\u00e1 E, Vranov\u00e1 V, Kugl\u00edk P, Cejpek P, Jarosov\u00e1 M, Pes\u00e1kov\u00e1 M, Relichov\u00e1 J, Veselsk\u00e1 R (2007) Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology. Neoplasma 54(3):212\u2013218","journal-title":"Neoplasma"},{"key":"2606_CR3","unstructured":"Kleihues P, Burger PC, Aldape KD, Brat DJ, Biernat W, Bigner DD, Nakazato Y, Plate KH, Giangaspero F, von Deimling A, Ohgaki H, Cavenee WK (2007) Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavanee WK (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 33\u201349"},{"key":"2606_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ana.22425","volume":"70","author":"M Preusser","year":"2011","unstructured":"Preusser M, de Ribaupierre S, Wohrer A, Erridge SC, Hegi M, Weller M, Stupp R (2011) Current concepts and management of glioblastoma. Ann Neurol 70:9\u201321","journal-title":"Ann Neurol"},{"issue":"Suppl 4","key":"2606_CR5","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012. Neuro Oncol 17(Suppl 4):iv1\u2013iv62","journal-title":"Neuro Oncol"},{"issue":"1","key":"2606_CR6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cancergencyto.2005.08.021","volume":"166","author":"M Hassler","year":"2006","unstructured":"Hassler M, Seidl S, Fazeny-Doerner B, Preusser M, Hainfellner J, R\u00f6ssler K, Prayer D, Marosi C (2006) Diversity of cytogenetic and pathohistologic profiles in glioblastoma. Cancer Genet Cytogenet 166(1):46\u201355","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"2606_CR7","first-page":"317","volume":"13","author":"M Medinger","year":"2016","unstructured":"Medinger M, Lengerke C, Passweg J (2016) Novel prognostic and therapeutic mutations in acute myeloid leukemia. Cancer Genomics Proteomics 13(5):317\u2013329","journal-title":"Cancer Genomics Proteomics"},{"issue":"23","key":"2606_CR8","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1158\/1078-0432.CCR-04-0710","volume":"10","author":"A Korshunov","year":"2004","unstructured":"Korshunov A, Sycheva R, Golanov A (2004) Molecular stratification of diagnostically challenging high-grade gliomas composed of small cells: the utility of fluorescence in situ hybridization. Clin Cancer Res 10(23):7820\u20137826","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2606_CR9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1215\/S1152851703000620","volume":"6","author":"KR Lamborn","year":"2004","unstructured":"Lamborn KR, Chang SM, Prados MD (2004) Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 6(3):227\u2013235","journal-title":"Neuro Oncol"},{"issue":"4","key":"2606_CR10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cncr.21221","volume":"104","author":"A Korshunov","year":"2005","unstructured":"Korshunov A, Sycheva R, Golanov A (2005) The prognostic relevance of molecular alterations in glioblastomas for patients age <50 years. Cancer 104(4):825\u2013832","journal-title":"Cancer"},{"issue":"10","key":"2606_CR11","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/cncr.23899","volume":"113","author":"FJ Rodriguez","year":"2008","unstructured":"Rodriguez FJ, Scheithauer BW, Giannini C, Bryant SC, Jenkins RB (2008) Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer 113(10):2779\u20132789","journal-title":"Cancer"},{"issue":"5","key":"2606_CR12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00428-007-0562-9","volume":"452","author":"LW Pinto","year":"2008","unstructured":"Pinto LW, Ara\u00fajo MB, Vettore AL, Wernersbach L, Leite AC, Chimelli LM, Soares FA (2008) Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis. Virchows Arch 452(5):481\u2013490","journal-title":"Virchows Arch"},{"issue":"1\u20132","key":"2606_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2010.03.019","volume":"294","author":"B Kim","year":"2010","unstructured":"Kim B, Myung JK, Seo JH, Park CK, Paek SH, Kim DG, Jung HW, Park SH (2010) The clinicopathologic values of the molecules associated with the main pathogenesis of the glioblastoma. J Neurol Sci 294(1\u20132):112\u2013118","journal-title":"J Neurol Sci"},{"issue":"3","key":"2606_CR14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13402-011-0034-8","volume":"34","author":"B Klink","year":"2011","unstructured":"Klink B, Schlingelhof B, Klink M, Stout-Weider K, Patt S, Schrock E (2011) Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification. Cell Oncol (Dordr) 34(3):261\u2013275","journal-title":"Cell Oncol (Dordr)"},{"key":"2606_CR15","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ncl.2007.07.008","volume":"25","author":"CJ Farrel","year":"2007","unstructured":"Farrel CJ, Plotkin SR (2007) Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Landau and other syndromes. Neurol Clin 25:925\u2013946","journal-title":"Neurol Clin"},{"issue":"2","key":"2606_CR16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ijc.11213","volume":"106","author":"B Malmer","year":"2003","unstructured":"Malmer B, Henriksson R, Gr\u00f6nberg H (2003) Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer 106(2):260\u2013263","journal-title":"Int J Cancer"},{"key":"2606_CR17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.clineuro.2015.10.002","volume":"139","author":"M Toledo","year":"2015","unstructured":"Toledo M, Sarria-Estrada S, Quintana M, Maldonado X, Martinez-Ricarte F, Rodon J, Auger C, Salas-Puig J, Santamarina E, Martinez-Saez E (2015) Prognostic implications of epilepsy in glioblastomas. Clin Neurol Neurosurg 139:166\u2013171","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"2606_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2015.07.148","volume":"465","author":"J Wang","year":"2015","unstructured":"Wang J, Su HK, Zhao HF, Chen ZP, To SS (2015) Progress in the application of molecular biomarkers in gliomas. Biochem Biophys Res Commun 465(1):1\u20134","journal-title":"Biochem Biophys Res Commun"},{"key":"2606_CR19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1474-4422(10)70105-8","volume":"9","author":"M Jansen","year":"2010","unstructured":"Jansen M, Yip S, Louis DN (2010) Molecular pathology in adult neuro-oncology: an update on diagnostic, prognostic and predictive markers. Lancet Neuro 9:717\u2013726","journal-title":"Lancet Neuro"},{"issue":"3","key":"2606_CR20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/NEN.0000000000000167","volume":"74","author":"P Mur","year":"2015","unstructured":"Mur P, Mollejo M, Hern\u00e1ndez-Iglesias T, de Lope \u00c1R, Castresana JS, Garc\u00eda JF, Fia\u00f1o C, Ribalta T, Rey JA, Mel\u00e9ndez B (2015) Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade. J Neuropathol Exp Neurol 74(3):241\u2013249","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"2606_CR21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2606_CR22","first-page":"413","volume":"63","author":"Y Okada","year":"2003","unstructured":"Okada Y, Hurwitz EE, Esposito JM, Brower MA, Nutt CL, Louis DN (2003) Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Cancer Res 63(2):413\u2013416","journal-title":"Cancer Res"},{"key":"2606_CR23","first-page":"1","volume":"20","author":"C Faulkner","year":"2014","unstructured":"Faulkner C, Palmer A, Williams H, Wragg C, Haynes HR, White P, DeSouza RM, Williams M, Hopkins K, Kurian KM (2014) EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers. Br J Neurosurg 20:1\u20137","journal-title":"Br J Neurosurg"},{"issue":"7","key":"2606_CR24","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1158\/0008-5472.CAN-11-4069","volume":"72","author":"SE Little","year":"2012","unstructured":"Little SE, Popov S, Jury A, Bax DA, Doey L, Al-Sarraj S, Jurgensmeier JM, Jones C (2012) Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity. Cancer Res 72(7):1614\u20131620","journal-title":"Cancer Res"},{"issue":"4","key":"2606_CR25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1440-1789.2009.01081.x","volume":"30","author":"R Benito","year":"2010","unstructured":"Benito R, Gil-Benso R, Quilis V, Perez M, Gregori-Romero M, Roldan P, Gonzalez-Darder J, Cerd\u00e1-Nicolas M, Lopez-Gines C (2010) Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features. Neuropathology 30(4):392\u2013400","journal-title":"Neuropathology"},{"issue":"6","key":"2606_CR26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/modpathol.2010.62","volume":"23","author":"C Lopez-Gines","year":"2010","unstructured":"Lopez-Gines C, Gil-Benso R, Ferrer-Luna R, Benito R, Serna E, Gonzalez-Darder J, Quilis V, Monleon D, Celda B, Cerd\u00e1-Nicolas M (2010) New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile. Mod Pathol 23(6):856\u2013865","journal-title":"Mod Pathol"},{"issue":"2","key":"2606_CR27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/path.1823","volume":"207","author":"H Joensuu","year":"2005","unstructured":"Joensuu H, Puputti M, Sihto H, Tynninen O, Nupponen NN (2005) Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. J Pathol 207(2):224\u2013231","journal-title":"J Pathol"},{"issue":"3","key":"2606_CR28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijrobp.2005.03.051","volume":"63","author":"AL Quan","year":"2005","unstructured":"Quan AL, Barnett GH, Lee SY, Vogelbaum MA, Toms SA, Staugaitis SM, Prayson RA, Peereboom DM, Stevens GH, Cohen BH, Suh JH (2005) Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 63(3):695\u2013703","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2606_CR29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5858\/2005-129-0624-GITOO","volume":"129","author":"BK Kleinschmidt-DeMasters","year":"2005","unstructured":"Kleinschmidt-DeMasters BK, Lillehei KO, Varella-Garcia M (2005) Glioblastomas in the older old. Arch Pathol Lab Med 129(5):624\u2013631","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"2606_CR30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1440-1827.1999.00934.x","volume":"49","author":"H Horiguchi","year":"1999","unstructured":"Horiguchi H, Hirose T, Sano T, Nagahiro S (1999) Loss of chromosome 10 in glioblastoma: relation to proliferation and angiogenesis. Pathol Int 49(8):681\u2013686","journal-title":"Pathol Int"},{"issue":"1","key":"2606_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1789.2004.00600.x","volume":"25","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H (2005) Genetic pathways to glioblastomas. Neuropathology 25(1):1\u20137","journal-title":"Neuropathology"},{"issue":"19","key":"2606_CR32","first-page":"5546","volume":"48","author":"CD James","year":"1988","unstructured":"James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK (1988) Clonal genomic alterations glioma malignancy stages. Cancer Res 48(19):5546\u20135551","journal-title":"Cancer Res"},{"issue":"16","key":"2606_CR33","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jnci\/93.16.1246","volume":"93","author":"JS Smith","year":"2001","unstructured":"Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, O\u2019Fallon JR, Schaefer PL, Scheithauer BW, James CD, Buckner JC, Jenkins RB (2001) PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 93(16):1246\u20131256","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2606_CR34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bpa.12018","volume":"23","author":"CL Appin","year":"2013","unstructured":"Appin CL, Gao J, Chisolm C, Torian M, Alexis D, Vincentelli C, Schniederjan MJ, Hadjipanayis C, Olson JJ, Hunter S, Hao C, Brat DJ (2013) Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics. Brain Pathol 23(4):454\u2013461","journal-title":"Brain Pathol"},{"issue":"2","key":"2606_CR35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/0028-3886.79139","volume":"59","author":"A Kakkar","year":"2011","unstructured":"Kakkar A, Suri V, Jha P, Srivastava A, Sharma V, Pathak P, Sharma MC, Sharma MS, Kale SS, Chosdol K, Phalak M, Sarkar C (2011) Loss of heterozygosity on chromosome 10q in glioblastomas, and its association with other genetic alterations and survival in Indian patients. Neurol India 59(2):254\u2013261","journal-title":"Neurol India"},{"issue":"10","key":"2606_CR36","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/cncr.21819","volume":"106","author":"C Houillier","year":"2006","unstructured":"Houillier C, Lejeune J, Benouaich-Amiel A, Laigle-Donadey F, Criniere E, Mokhtari K, Thillet J, Delattre JY, Hoang-Xuan K, Sanson M (2006) Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer 106(10):2218\u20132223","journal-title":"Cancer"},{"issue":"9","key":"2606_CR37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.4161\/cbt.7.9.6954","volume":"7","author":"D Koul","year":"2008","unstructured":"Koul D (2008) PTEN signaling pathways in glioblastoma. Cancer Biol Ther 7(9):1321\u20131325","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"2606_CR38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.tranon.2014.02.004","volume":"7","author":"J Xu","year":"2014","unstructured":"Xu J, Li Z, Wang J, Chen H, Fang JY (2014) Combined PTEN Mutation and Protein Expression Associate with Overall and Disease-Free Survival of Glioblastoma Patients. Transl Oncol 7(2):196\u2013205.e1","journal-title":"Transl Oncol"},{"issue":"3","key":"2606_CR39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1440-1827.2001.01186.x","volume":"51","author":"H Horiguchi","year":"2001","unstructured":"Horiguchi H, Sano T, Hirose T (2001) TP53 deleted cells in de novo glioblastomas using fluorescence in situ hybridization. Pathol Int 51(3):187\u2013192","journal-title":"Pathol Int"},{"issue":"1","key":"2606_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1750-3639.1993.tb00721.x","volume":"3","author":"A Deimling von","year":"1993","unstructured":"von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN (1993) Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3(1):19\u201326","journal-title":"Brain Pathol"},{"issue":"2","key":"2606_CR41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1309\/AJCP64YBDVCTIRWV","volume":"131","author":"Y Ruano","year":"2009","unstructured":"Ruano Y, Ribalta T, de Lope AR, Campos-Martin Y, Fiano C, Perez-Magan E, Hern\u00e1ndez-Moneo JL, Mollejo M, Mel\u00e9ndez B (2009) Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration. Am J Clin Pathol 131(2):257\u2013263","journal-title":"Am J Clin Pathol"},{"key":"2606_CR42","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1158\/0008-5472.CAN-04-3936","volume":"65","author":"JN Rich","year":"2005","unstructured":"Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BKA, Dobra A, Dressman HK, Bigner DD, Nevins JR, West M (2005) Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 65:4051\u20134058","journal-title":"Cancer Res"},{"key":"2606_CR43","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1158\/1078-0432.CCR-08-2801","volume":"15","author":"J Felsberg","year":"2009","unstructured":"Felsberg J, Rapp M, Loeser S, Fimmers R, Stummer W, Goeppert M, Steiger HJ, Friedensdorf B, Reifenberger G, Sabel MC (2009) Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients. Clin Cancer Res 15:6683\u20136693","journal-title":"Clin Cancer Res"},{"key":"2606_CR44","doi-asserted-by":"crossref","first-page":"654727","DOI":"10.1155\/2014\/654727","volume":"2014","author":"G Stancheva","year":"2014","unstructured":"Stancheva G, Goranova T, Laleva M, Kamenova M, Mitkova A, Velinov N, Poptodorov G, Mitev V, Kaneva R, Gabrovsky N (2014) IDH1\/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patients. Biomed Res Int 2014:654727","journal-title":"Biomed Res Int"},{"issue":"3","key":"2606_CR45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ijrobp.2005.03.059","volume":"63","author":"HA Shih","year":"2005","unstructured":"Shih HA, Betensky RA, Dorfman MV, Louis DN, Loeffler JS, Batchelor TT (2005) Genetic analyses for predictors of radiation response in glioblastoma. Int J Radiat Oncol Biol Phys 63(3):704\u2013710","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2606_CR46","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1245\/s10434-013-3380-0","volume":"21","author":"X Wang","year":"2014","unstructured":"Wang X, Chen JX, Liu JP, You C, Liu YH, Mao Q (2014) Gain of function of mutant TP53 in glioblastoma: prognosis and response to temozolomide. Ann Surg Oncol 21(4):1337\u20131344","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"2606_CR47","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10072-012-1257-9","volume":"34","author":"X Wang","year":"2013","unstructured":"Wang X, Chen JX, Liu YH, You C, Mao Q (2013) Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O(6)-methylguanine DNA-methyltransferase. Neurol Sci 34(8):1421\u20131428","journal-title":"Neurol Sci"},{"issue":"9","key":"2606_CR48","first-page":"1793","volume":"58","author":"M Tada","year":"1998","unstructured":"Tada M, Matsumoto R, Iggo RD, Onimaru R, Shirato H, Sawamura Y, Shinohe Y (1998) Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations. Cancer Res 58(9):1793\u20131797","journal-title":"Cancer Res"},{"issue":"2","key":"2606_CR49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10014-010-0272-x","volume":"27","author":"H Momota","year":"2010","unstructured":"Momota H, Narita Y, Matsushita Y, Miyakita Y, Shibui S (2010) p53 abnormality and tumor invasion in patients with malignant astrocytoma. Brain Tumor Pathol 27(2):95\u2013101","journal-title":"Brain Tumor Pathol"},{"issue":"4","key":"2606_CR50","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bjc.1994.373","volume":"70","author":"S Leenstra","year":"1994","unstructured":"Leenstra S, Bijlsma EK, Troost D, Oosting J, Westerveld A, Bosch DA, Hulsebos TJ (1994) Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis. Br J Cancer 70(4):684\u2013689","journal-title":"Br J Cancer"},{"issue":"1","key":"2606_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10014-006-0209-6","volume":"24","author":"T Nagasaka","year":"2007","unstructured":"Nagasaka T, Gunji M, Hosokai N, Hayashi K, Ikeda H, Ito M, Inao S (2007) FISH 1p\/19q deletion\/imbalance for molecular subclassification of glioblastoma. Brain Tumor Pathol 24(1):1\u20135","journal-title":"Brain Tumor Pathol"},{"issue":"6","key":"2606_CR52","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/PAI.0b013e3181a2c6a4","volume":"17","author":"D Kaneshiro","year":"2009","unstructured":"Kaneshiro D, Kobayashi T, Chao ST, Suh J, Prayson RA (2009) Chromosome 1p and 19q deletions in glioblastoma multiforme. Appl Immunohistochem Mol Morphol 17(6):512\u2013516","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"6","key":"2606_CR53","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/nan.12031","volume":"39","author":"KH Clark","year":"2013","unstructured":"Clark KH, Villano JL, Nikiforova MN, Hamilton RL, Horbinski C (2013) 1p\/19q testing has no significance in the workup of glioblastomas. Neuropathol Appl Neurobiol 39(6):706\u2013717","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2606-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T19:09:04Z","timestamp":1659380944000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2606-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2606"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2606-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]}}}